Lineage Cell Therapeutics (LCTX) Asset Writedowns and Impairment (2011 - 2025)
Lineage Cell Therapeutics' (LCTX) quarterly Asset Writedowns and Impairment came in at $14.8 million in Q2 2025, up 9900.0% quarter-over-quarter from $148000.0 in Q4 2016.
Lineage Cell Therapeutics (LCTX) Asset Writedowns and Impairment (2011 - 2025) Analysis & Trends
Lineage Cell Therapeutics' Asset Writedowns and Impairment history runs 6 years deep, the most recent figure standing at $14.8 million for Q2 2025.
- On a quarterly basis, Asset Writedowns and Impairment changed N/A year-over-year to $14.8 million in Q2 2025; TTM through Dec 2025 was $14.8 million, a 9900.0% increase from a year earlier, with the FY2025 full-year figure at $14.8 million, changed N/A from the prior year.
- Asset Writedowns and Impairment improved to $14.8 million in Q2 2025 per LCTX's latest filing, from $148000.0 in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $14.8 million in Q2 2025 and bottomed at $14.8 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,140.12 Bn | 66,139.83 Bn | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - |
| 4 | BeOne Medicines | 472.04 Bn | 467.25 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.28 Bn | 115.03 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.07 Bn | 61.31 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.66 Bn | 62.66 Bn | - |
| 8 | Argenx Se | 56.16 Bn | 50.98 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.56 Bn | 34.55 Bn | 959.66 Mn |
| 10 | Lineage Cell Therapeutics | 249.93 Mn | 187.21 Mn | 1.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 14.80 Mn |
| Jun 30, 2025 | 14.80 Mn |
| Dec 31, 2016 | 148,000.00 |
| Dec 31, 2016 | 148,000.00 |
| Sep 30, 2016 | 448,000.00 |
| Sep 30, 2016 | 448,000.00 |
| Dec 31, 2014 | -25,000.00 |
| Dec 31, 2014 | -25,000.00 |
| Sep 30, 2014 | -12,000.00 |
| Sep 30, 2014 | -12,000.00 |
| Jun 30, 2014 | 12,424.00 |
| Jun 30, 2014 | 12,424.00 |
| Mar 31, 2014 | 8,576.00 |
| Mar 31, 2014 | 8,576.00 |
| Dec 31, 2013 | 120.00 |
| Dec 31, 2013 | 120.00 |
| Sep 30, 2013 | -5,830.00 |
| Sep 30, 2013 | -5,830.00 |
| Jun 30, 2013 | -813.00 |
| Jun 30, 2013 | -813.00 |